Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Shares Outstanding (Weighted Average) (2021 - 2025)

Historic Shares Outstanding (Weighted Average) for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to $10.8 million.

  • Biofrontera's Shares Outstanding (Weighted Average) rose 8664.27% to $10.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.8 million, marking a year-over-year increase of 8664.27%. This contributed to the annual value of $5.5 million for FY2024, which is 25674.48% up from last year.
  • As of Q3 2025, Biofrontera's Shares Outstanding (Weighted Average) stood at $10.8 million, which was up 8664.27% from $9.4 million recorded in Q2 2025.
  • Over the past 5 years, Biofrontera's Shares Outstanding (Weighted Average) peaked at $17.1 million during Q1 2022, and registered a low of $941175.0 during Q2 2022.
  • For the 5-year period, Biofrontera's Shares Outstanding (Weighted Average) averaged around $5.7 million, with its median value being $5.5 million (2024).
  • In the last 5 years, Biofrontera's Shares Outstanding (Weighted Average) soared by 79990000.0% in 2021 and then tumbled by 9219.54% in 2023.
  • Quarter analysis of 5 years shows Biofrontera's Shares Outstanding (Weighted Average) stood at $8.8 million in 2021, then plummeted by 88.0% to $1.1 million in 2022, then skyrocketed by 46.29% to $1.5 million in 2023, then surged by 256.74% to $5.5 million in 2024, then skyrocketed by 95.36% to $10.8 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $10.8 million in Q3 2025, compared to $9.4 million in Q2 2025 and $8.9 million in Q1 2025.